Total Valuation
Lexicon Pharmaceuticals has a market cap or net worth of €889.74M. The enterprise value is €919.00.
Market Cap€889.74M
Enterprise Value€919.00
Share Statistics
Lexicon Pharmaceuticals has 444,196,380 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding444,196,380
Owned by Insiders61.35%
Owned by Institutions0.27%
Financial Efficiency
Lexicon Pharmaceuticals’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -28.71%.
Return on Equity (ROE)-0.47
Return on Assets (ROA)-0.27
Return on Invested Capital (ROIC)-28.71%
Return on Capital Employed (ROCE)-0.30
Revenue Per Employee614.85K
Profits Per Employee-621.49K
Employee Count81
Asset Turnover0.27
Inventory Turnover0.98
Valuation Ratios
The current PE Ratio of Lexicon Pharmaceuticals is ―. Lexicon Pharmaceuticals’s PEG ratio is 0.11.
PE Ratio―
PS Ratio8.38
PB Ratio3.88
Price to Fair Value3.88
Price to FCF-6.15
Price to Operating Cash Flow-13.56
PEG Ratio0.11
Income Statement
In the last 12 months, Lexicon Pharmaceuticals had revenue of 49.80M and earned -50.34M in profits. Earnings per share was -0.14.
Revenue49.80M
Gross Profit49.53M
Operating Income-48.91M
Pretax Income-50.34M
Net Income-50.34M
EBITDA-41.38M
Earnings Per Share (EPS)-0.14
Cash Flow
In the last 12 months, operating cash flow was -79.72M and capital expenditures 0.00, giving a free cash flow of -79.72M billion.
Operating Cash Flow-79.72M
Free Cash Flow-79.72M
Free Cash Flow per Share-0.18
Dividends & Yields
Lexicon Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.84
52-Week Price Change11.89%
50-Day Moving Average1.01
200-Day Moving Average1.04
Relative Strength Index (RSI)39.07
Average Volume (3m)0.00
Important Dates
Lexicon Pharmaceuticals upcoming earnings date is Nov 11, 2026, Before Open (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
Lexicon Pharmaceuticals as a current ratio of 4.88, with Debt / Equity ratio of 0.00%
Current Ratio4.88
Quick Ratio4.87
Debt to Market Cap0.13
Net Debt to EBITDA-0.67
Interest Coverage Ratio-5.87
Taxes
In the past 12 months, Lexicon Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Lexicon Pharmaceuticals EV to EBITDA ratio is -10.76, with an EV/FCF ratio of -6.56.
EV to Sales8.94
EV to EBITDA-10.76
EV to Free Cash Flow-6.56
EV to Operating Cash Flow-6.56
Balance Sheet
Lexicon Pharmaceuticals has €190.61M in cash and marketable securities with €0.00 in debt, giving a net cash position of €190.61M billion.
Cash & Marketable Securities€190.61M
Total Debt€0.00
Net Cash€190.61M
Net Cash Per Share€0.43
Tangible Book Value Per Share€0.17
Margins
Gross margin is 98.85%, with operating margin of -98.21%, and net profit margin of -101.08%.
Gross Margin98.85%
Operating Margin-98.21%
Pretax Margin-101.08%
Net Profit Margin-101.08%
EBITDA Margin-83.09%
EBIT Margin-84.34%
Analyst Forecast
The average price target for Lexicon Pharmaceuticals is €4.37, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€4.37
Price Target Upside332.51% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―